Diagnostic and Therapeutic Potentials of Platelet Glycoprotein VI

 

 Buy Article Permissions and Reprints

ABSTRACT

Platelets respond immediately to vascular injury by adhesion, aggregation, and thrombus formation. Disruption of the endothelial cell layer exposes extracellular matrix to the bloodstream. Collagen binding to platelet glycoprotein VI (GPVI) mediates the initial adhesion of the rolling platelet to the vascular wound. Signaling by GPVI leads to the onset of the platelet activation cascade that is finally crowned by a firm and shear-resistant integrin-based adhesive clot. Blockade of collagen binding to GPVI would prevent initial adhesion and further activation of the platelet and would have an enormous impact in antithrombotic therapy. Besides the therapeutical implication, radiolabeled GPVI gives us a valuable diagnostic means that may be used clinically for plaque imaging in the near future.

REFERENCES

• 1 Ginsberg M H, Loftus J, Plow E F. Platelets and the adhesion receptor superfamily.  Prog Clin Biol Res. 1988;  283 171-195
  PubMedGoogle Scholar
• 2 Shen Y, Romo G M, Dong J F et al.. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.  Blood. 2000;  95(3) 903-910
  PubMedGoogle Scholar
• 3 Kandzari D E, Goldschmidt-Clermont P J. Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors.  J Am Coll Cardiol. 2001;  38(4) 1028-1032
  CrossrefPubMedGoogle Scholar
• 4 Simon D I, Chen Z, Xu H et al.. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).  J Exp Med. 2000;  192(2) 193-204
  CrossrefPubMedGoogle Scholar
• 5 Glass C K, Witztum J L. Atherosclerosis. the road ahead.  Cell. 2001;  104(4) 503-516
  CrossrefPubMedGoogle Scholar
• 6 Shah P K, Falk E, Badimon J J et al.. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.  Circulation. 1995;  92(6) 1565-1569
  PubMedGoogle Scholar
• 7 Clemetson K J, McGregor J L, James E, Dechavanne M, Lüscher E F. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis.  J Clin Invest. 1982;  70(2) 304-311
  CrossrefPubMedGoogle Scholar
• 8 Moroi M, Jung S M, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.  J Clin Invest. 1989;  84(5) 1440-1445
  CrossrefPubMedGoogle Scholar
• 9 Moroi M, Jung S M. Platelet glycoprotein VI: its structure and function.  Thromb Res. 2004;  114(4) 221-233
  CrossrefPubMedGoogle Scholar
• 10 Clemetson J M, Polgar J, Magnenat E, Wells T N, Clemetson K J. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.  J Biol Chem. 1999;  274(41) 29019-29024
  CrossrefPubMedGoogle Scholar
• 11 Locke D, Liu C, Peng X, Chen H, Kahn M L. Fc Rgamma—independent signaling by the platelet collagen receptor glycoprotein VI.  J Biol Chem. 2003;  278(17) 15441-15448
  CrossrefPubMedGoogle Scholar
• 12 Takai T, Li M, Sylvestre D, Clynes R, Ravetch J V. FcR gamma chain deletion results in pleiotrophic effector cell defects.  Cell. 1994;  76(3) 519-529
  CrossrefPubMedGoogle Scholar
• 13 Asselin J, Gibbins J M, Achison M et al.. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1.  Blood. 1997;  89(4) 1235-1242
  PubMedGoogle Scholar
• 14 Poole A, Gibbins J M, Turner M et al.. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen.  EMBO J. 1997;  16(9) 2333-2341
  CrossrefPubMedGoogle Scholar
• 15 Ichinohe T, Takayama H, Ezumi Y et al.. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI.  J Biol Chem. 1997;  272(1) 63-68
  CrossrefPubMedGoogle Scholar
• 16 Gross B S, Lee J R, Clements J L et al.. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets.  J Biol Chem. 1999;  274(9) 5963-5971
  CrossrefPubMedGoogle Scholar
• 17 Pasquet J M, Gross B, Quek L et al.. LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI.  Mol Cell Biol. 1999;  19(12) 8326-8334
  PubMedGoogle Scholar
• 18 Watson S P, Asazuma N, Atkinson B et al.. The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen.  Thromb Haemost. 2001;  86(1) 276-288
  PubMedGoogle Scholar
• 19 Asazuma N, Wilde J I, Berlanga O et al.. Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin.  J Biol Chem. 2000;  275(43) 33427-33434
  CrossrefPubMedGoogle Scholar
• 20 Locke D, Chen H, Liu Y, Liu C, Kahn M L. Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI.  J Biol Chem. 2002;  277(21) 18801-18809
  CrossrefPubMedGoogle Scholar
• 21 Gibbins J M, Briddon S, Shutes A et al.. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor γ-chain and linker for activator of T cells (LAT) in platelets stimulated by collagen and convulxin.  J Biol Chem. 1998;  273(51) 34437-34443
  CrossrefPubMedGoogle Scholar
• 22 Watanabe N, Nakajima H, Suzuki H et al.. Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation.  Blood. 2003;  102(2) 541-548
  CrossrefPubMedGoogle Scholar
• 23 Canobbio I, Stefanini L, Cipolla L et al.. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets.  Blood. 2009;  114(10) 2193-2196
  CrossrefPubMedGoogle Scholar
• 24 Kim S, Mangin P, Dangelmaier C et al.. Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets.  J Biol Chem. 2009;  284(49) 33763-33772
  CrossrefPubMedGoogle Scholar
• 25 Savage B, Almus-Jacobs F, Ruggeri Z M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.  Cell. 1998;  94(5) 657-666
  CrossrefPubMedGoogle Scholar
• 26 Sixma J J, van Zanten G H, Saelman E U et al.. Platelet adhesion to collagen.  Thromb Haemost. 1995;  74(1) 454-459
  PubMedGoogle Scholar
• 27 Sixma J J, van Zanten G H, Huizinga E G et al.. Platelet adhesion to collagen: an update.  Thromb Haemost. 1997;  78(1) 434-438
  PubMedGoogle Scholar
• 28 Jung S M, Moroi M. Platelets interact with soluble and insoluble collagens through characteristically different reactions.  J Biol Chem. 1998;  273(24) 14827-14837
  CrossrefPubMedGoogle Scholar
• 29 Miura Y, Takahashi T, Jung S M, Moroi M. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen.  J Biol Chem. 2002;  277(48) 46197-46204
  CrossrefPubMedGoogle Scholar
• 30 Polgár J, Clemetson J M, Kehrel B E et al.. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor.  J Biol Chem. 1997;  272(21) 13576-13583
  CrossrefPubMedGoogle Scholar
• 31 Jandrot-Perrus M, Lagrue A H, Okuma M, Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin α2β1.  J Biol Chem. 1997;  272(43) 27035-27041
  CrossrefPubMedGoogle Scholar
• 32 Keely P J, Parise L V. The α2β1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets.  J Biol Chem. 1996;  271(43) 26668-26676
  CrossrefPubMedGoogle Scholar
• 33 Trifiro E, Williams S A, Cheli Y et al.. The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.  Blood. 2009;  114(9) 1893-1899
  CrossrefPubMedGoogle Scholar
• 34 Joutsi-Korhonen L, Smethurst P A, Rankin A et al.. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.  Blood. 2003;  101(11) 4372-4379
  CrossrefPubMedGoogle Scholar
• 35 Watkins N A, O'Connor M N, Rankin A et al.. Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms.  J Thromb Haemost. 2006;  4(6) 1197-1205
  CrossrefPubMedGoogle Scholar
• 36 Nurden A. GPVI: the inside story.  Blood. 2009;  114(9) 1723-1724
  CrossrefPubMedGoogle Scholar
• 37 Dumont B, Lasne D, Rothschild C et al.. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.  Blood. 2009;  114(9) 1900-1903
  CrossrefPubMedGoogle Scholar
• 38 Hermans C, Wittevrongel C, Thys C, Smethurst P A, Van Geet C, Freson K. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.  J Thromb Haemost. 2009;  7(8) 1356-1363
  CrossrefPubMedGoogle Scholar
• 39 Massberg S, Konrad I, Bültmann A et al.. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.  FASEB J. 2004;  18(2) 397-399
  PubMedGoogle Scholar
• 40 Massberg S, Gawaz M, Grüner S et al.. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.  J Exp Med. 2003;  197(1) 41-49
  CrossrefPubMedGoogle Scholar
• 41 Nieswandt B, Brakebusch C, Bergmeier W et al.. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.  EMBO J. 2001;  20(9) 2120-2130
  CrossrefPubMedGoogle Scholar
• 42 Grüner S, Prostredna M, Koch M et al.. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.  Blood. 2005;  105(4) 1492-1499
  CrossrefPubMedGoogle Scholar
• 43 Al-Tamimi M, Mu F T, Moroi M, Gardiner E E, Berndt M C, Andrews R K. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.  Platelets. 2009;  20(3) 143-149
  CrossrefPubMedGoogle Scholar
• 44 Bigalke B, Geisler T, Stellos K et al.. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.  Am Heart J. 2008;  156(1) 193-200
  CrossrefPubMedGoogle Scholar
• 45 Bigalke B, Stellos K, Geisler T et al.. Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke.  Eur J Neurol. 2010;  17 111-117
  CrossrefPubMedGoogle Scholar
• 46 Ruggeri Z M. Platelets in atherothrombosis.  Nat Med. 2002;  8(11) 1227-1234
  CrossrefPubMedGoogle Scholar
• 47 Remijn J A, Wu Y P, Jeninga E H et al.. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.  Arterioscler Thromb Vasc Biol. 2002;  22(4) 686-691
  CrossrefPubMedGoogle Scholar
• 48 Kunapuli S P, Dorsam R T, Kim S, Quinton T M. Platelet purinergic receptors.  Curr Opin Pharmacol. 2003;  3(2) 175-180
  CrossrefPubMedGoogle Scholar
• 49 Siljander P R, Munnix I C, Smethurst P A et al.. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood.  Blood. 2004;  103(4) 1333-1341
  CrossrefPubMedGoogle Scholar
• 50 Zwaal R F, Schroit A J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.  Blood. 1997;  89(4) 1121-1132
  PubMedGoogle Scholar
• 51 Lindemann S, Tolley N D, Eyre J R, Kraiss L W, Mahoney T M, Weyrich A S. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control.  J Biol Chem. 2001;  276(36) 33947-33951
  CrossrefPubMedGoogle Scholar
• 52 Lindemann S, Tolley N D, Dixon D A et al.. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.  J Cell Biol. 2001;  154(3) 485-490
  CrossrefPubMedGoogle Scholar
• 53 Barnes M J, Farndale R W. Collagens and atherosclerosis.  Exp Gerontol. 1999;  34(4) 513-525
  CrossrefPubMedGoogle Scholar
• 54 Badimon L. Atherosclerosis and thrombosis: lessons from animal models.  Thromb Haemost. 2001;  86(1) 356-365
  PubMedGoogle Scholar
• 55 Galt S W, Lindemann S, Medd D et al.. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.  Circ Res. 2001;  89(6) 509-516
  CrossrefPubMedGoogle Scholar
• 56 Galt S W, Lindemann S, Allen L et al.. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function.  Circ Res. 2002;  90(10) 1093-1099
  CrossrefPubMedGoogle Scholar
• 57 Cosemans J M, Kuijpers M J, Lecut C et al.. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions.  Atherosclerosis. 2005;  181(1) 19-27
  CrossrefPubMedGoogle Scholar
• 58 Cabeza N, Li Z, Schulz C et al.. Surface expression of collagen receptor Fc receptor-γ/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells.  Diabetes. 2004;  53(8) 2117-2121
  CrossrefPubMedGoogle Scholar
• 59 Heeschen C, Dimmeler S, Hamm C W CAPTURE Study Investigators et al. Soluble CD40 ligand in acute coronary syndromes.  N Engl J Med. 2003;  348(12) 1104-1111
  CrossrefPubMedGoogle Scholar
• 60 Bigalke B, Lindemann S, Ehlers R et al.. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.  Eur Heart J. 2006;  27(18) 2165-2169
  CrossrefPubMedGoogle Scholar
• 61 Massberg S, Konrad I, Bültmann A et al.. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.  FASEB J. 2004;  18(2) 397-399
  PubMedGoogle Scholar
• 62 Gawaz M, Konrad I, Hauser A I et al.. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.  Thromb Haemost. 2005;  93(5) 910-913
  PubMedGoogle Scholar
• 63 Bültmann A, Herdeg C, Li Z et al.. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.  Thromb Haemost. 2006;  95(5) 763-766
  PubMedGoogle Scholar
• 64 Bigalke B, Stellos K, Weig H J et al.. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).  Basic Res Cardiol. 2009;  104(3) 352-357
  CrossrefPubMedGoogle Scholar
• 65 Bigalke B, Stellos K, Stakos D et al.. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.  Thromb Haemost. 2009;  101(5) 911-915
  PubMedGoogle Scholar
• 66 Bigalke B, Stellos K, Geisler T et al.. Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease.  Clin Res Cardiol. 2010;  , January 5 (Epub ahead of print)
  PubMedGoogle Scholar
• 67 Bigalke B, Haap M, Stellos K et al.. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain.  Thromb Res. 2010;  , January 30 (Epub ahead of print)
  PubMedGoogle Scholar
• 68 Bigalke B, Stellos K, Geisler T et al.. Glycoprotein VI for diagnosis of acute coronary syndrome when the ECG is ambiguous.  Int J Cardiol. 2010;  , January 11 (Epub ahead of print)
  PubMedGoogle Scholar

Boris BigalkeM.D. 

Medizinische Klinik III, Eberhard-Karls-Universität Tübingen

Otfried-Müller-Str.10, D-72076 Tübingen, Germany

Email: boris.bigalke@med.uni-tuebingen.de